Algeria vs Cote d'Ivoire: Access to anti-retroviral drugs, male (%)
Algeria
68.0%
in 2024
Cote d'Ivoire
69.0%
in 2024
Algeria rank
73rd
Cote d'Ivoire rank
72nd
Access to anti-retroviral drugs, male (%) over time
- Algeria
- Cote d'Ivoire
How they compare
Cote d'Ivoire currently reports 69.0% against 68.0% in Algeria, a difference of 1.0%.
The two have swapped places 1 time across 25 shared years of data; in 2000 it was Algeria ahead.
Algeria ranks 73rd and Cote d'Ivoire ranks 72nd of 141 countries.
Algeria has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Algeria | Cote d'Ivoire | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 13.3% | 3.4% | 9.9% | Algeria |
| 2010s | 42.6% | 28.6% | 14.0% | Algeria |
| 2020s | 69.6% | 61.2% | 8.4% | Algeria |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Algeria or Cote d'Ivoire?
- Cote d'Ivoire, at 69.0% against 68.0% in Algeria as of 2024.
- What is the difference in access to anti-retroviral drugs, male between Algeria and Cote d'Ivoire?
- 1.0%, with Cote d'Ivoire ahead.
- How many years of comparable data are there for Algeria and Cote d'Ivoire?
- 25 years are reported by both, from 2000 to 2024.
- How do Algeria and Cote d'Ivoire rank globally for access to anti-retroviral drugs, male?
- Algeria ranks 73rd and Cote d'Ivoire ranks 72nd of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.